Question 1

What is Ibrance?

Accepted Answer

Ibrance is a medication that contains the active ingredient palbociclib and is classified as a kinase inhibitor. It is designed to target specific proteins in the body that contribute to the development of cancer cells.

The drug works by blocking the activity of cyclin-dependent kinases 4 and 6, which are proteins that regulate cell growth and division. By inhibiting these proteins, the medication helps to slow or stop the growth of cancer cells.

Question 2

What is Ibrance used for?

Accepted Answer

Ibrance is used to treat hormone receptor-positive , HER2-negative breast cancer.

Question 3

How does Ibrance work?

Accepted Answer

Mechanism of Action

Ibrance belongs to a class of drugs known as kinase inhibitors. It is a targeted therapy that specifically interferes with the process cancer cells use to multiply.

Targeting CDK4 and CDK6 Proteins

Inside the body, certain proteins called cyclin-dependent kinases (specifically CDK4 and CDK6) regulate the cell cycle, which is the process cells go through to grow and divide. In some types of breast cancer, these proteins become overactive, signaling the cancer cells to divide rapidly and uncontrollably.

Ibrance works by:

Blocking Protein Activity: The medication attaches to CDK4 and CDK6 proteins to stop them from sending growth signals.

Interrupting the Cell Cycle: By inhibiting these proteins, Ibrance prevents cancer cells from moving from one stage of growth to the next.

Slowing Progression: When the cell cycle is interrupted, the cancer cells cannot reproduce as quickly, which can help shrink tumors or prevent them from growing larger.

This medication is used for cancers that are hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-). It is typically used in combination with hormone therapy to provide a dual approach to stopping cancer cell growth.

Question 4

What are the active ingredients in Ibrance?

Accepted Answer

The active ingredient in Ibrance is palbociclib .

Question 5

What are the side effects of Ibrance?

Accepted Answer

Common side effects of Ibrance may include:

Fatigue

Nausea

Diarrhea

and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Ibrance?

Accepted Answer

Ibrance belongs to the CDK4/6 inhibitor drug class.

Question 7

What is the dosage of Ibrance and how do I take it?

Accepted Answer

How to Take Ibrance

Ibrance is taken by mouth once daily, usually at the same time each day. It is typically prescribed in a cycle that consists of taking the medication for 21 consecutive days followed by 7 days off. This 28-day cycle is then repeated as directed by a healthcare professional.

Food Requirements

Capsules: These should always be taken with food.

Tablets: These can be taken with or without food.

General Instructions

Swallow the capsules or tablets whole. Do not chew, crush, or open them before swallowing. If a capsule or tablet is broken, cracked, or damaged, do not use it. You should also avoid grapefruit and grapefruit products while taking this medication, as they can interfere with how the drug is processed by your body.

Missed Doses

If you miss a dose or if you vomit after taking a dose, do not take an extra dose. Skip the missed dose and take your next dose at the usual scheduled time. Do not take two doses at once to make up for a missed one.

Question 8

Is Ibrance safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Considerations

Ibrance can cause harm to a developing fetus. Healthcare providers typically perform a pregnancy test before starting treatment to ensure the patient is not pregnant. If pregnancy occurs during treatment, it is important to inform a healthcare professional immediately.

Contraception

Because of the risk of fetal harm, specific contraception timelines are recommended for patients and their partners:

Females: Those who can become pregnant should use effective birth control during treatment and for 3 weeks after the last dose.

Males: Men with female partners of reproductive potential should use effective birth control during treatment and for 14 weeks after the last dose.

Breastfeeding

It is not known if this medication passes into breast milk. To avoid potential risks to a nursing child, breastfeeding is not recommended during treatment and for at least 3 weeks after the final dose.

Fertility

Based on findings in animal studies, Ibrance may impair male fertility. Patients may wish to discuss reproductive health and potential options with their clinical team before beginning therapy.

Question 9

What forms and strengths does Ibrance come in?

Accepted Answer

Available Forms

Ibrance is supplied in the following oral forms:

Capsules

Tablets

Both the capsules and tablets are intended to be swallowed whole. They should not be crushed, chewed, or opened. While the capsules must be taken with food, the tablets can be taken with or without a meal.

Question 10

What is the FDA approval status of Ibrance?

Accepted Answer

FDA Approval and Indications

Ibrance (palbociclib) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It is used in the following treatment regimens:

In combination with an aromatase inhibitor as the initial endocrine-based therapy.

In combination with fulvestrant for patients whose disease has progressed following endocrine therapy.

Regulatory Safety Information

The FDA monitors the safety of approved medications through various reporting systems. In 2020, the FDA identified a potential signal of serious risk regarding interstitial lung disease (ILD) and pneumonitis associated with the use of CDK4/6 inhibitors, including Ibrance. The agency determined that the product labeling should include information about these risks.

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) programs required for Ibrance. Patients are typically monitored through regular blood tests and clinical evaluations to manage potential side effects such as low white blood cell counts.

Question 11

What should I know about Ibrance and cost?

Accepted Answer

Factors Influencing Cost

The price you pay for Ibrance can vary based on several factors:

Insurance Coverage: Your specific health insurance plan, including your deductible and copayment or coinsurance requirements, will determine your out-of-pocket costs.

Pharmacy Choice: Ibrance is a specialty medication and may only be available through specific specialty pharmacies, which can influence the price.

Dosage: While different strengths often have similar pricing, the total cost may depend on the specific treatment cycle prescribed by your healthcare provider.

Generic Availability

Currently, Ibrance is only available as a brand-name drug. There is no generic version of palbociclib available at this time, which typically means the cost remains higher than it would be for a generic alternative.

Financial Assistance Programs

Because Ibrance is a specialty medication, there are options that may help reduce the cost for eligible patients:

Manufacturer Support: The drug manufacturer may offer copay cards or savings programs for people with commercial insurance to help lower out-of-pocket expenses.

Patient Assistance Programs: For those without insurance or who are underinsured, non-profit organizations or the manufacturer may provide the medication at a lower cost or for free based on financial need.

Medicare Coverage: Most Medicare Part D plans cover Ibrance, though it is often placed on a high-cost specialty tier, which may result in significant coinsurance costs during certain phases of coverage.

It is recommended to contact your insurance provider or speak with a specialty pharmacist to get an accurate estimate of your specific costs.

Ibrance

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?